Susquehanna International Group, LLP Tiziana Life Sciences LTD Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 57,330 shares of TLSA stock, worth $94,594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,330Holding current value
$94,594% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding TLSA
# of Institutions
35Shares Held
3.04MCall Options Held
24KPut Options Held
800-
Dauntless Investment Group, LLC Commerce Township, MI1.74MShares$2.87 Million2.2% of portfolio
-
Jane Street Group, LLC New York, NY168KShares$276,4440.0% of portfolio
-
Omers Administration Corp Toronto, A6145KShares$239,0850.0% of portfolio
-
Morgan Stanley New York, NY139KShares$229,4020.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$173,8520.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $169M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...